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Given their druthers, bacteria prefer a community-based,
surface-bound, sedentary lifestyle to a nomadic existence. Zo-
Bell and others (45, 62, 89, 98, 100) recognized this tendency
early in the twentieth century as a habitual characteristic of
aquatic bacterial populations. In fact, these early observations
provided tremendous insight into contemporary models of bac-
terial adhesion, given the unavailability of analytic and molec-
ular tools at the time.
In natural aquatic ecosystems, surface-associated microor-
ganisms vastly outnumber organisms in suspension (100). The
propensity for bacteria to colonize surfaces is advantageous
from an ecological standpoint because it preferentially targets
specialized microorganisms to specific locations, encouraging
symbiotic relationships. Examples of these relationships are
abundant in nature and include the prokaryotic diazotrophs
that colonize the roots of legumes (76) and the diverse resi-
dential microbial flora inhabiting the digestive tract of rumi-
nants that promotes the degradation and recycling of insoluble
materials (10).
The inclination for bacteria to become surface bound is so
ubiquitous in diverse ecosystems that it suggests a strong sur-
vival and/or selective advantage for surface dwellers over their
free-ranging counterparts (17, 20, 100). There may be an ob-
vious explanation for bacterial adhesion, because nutrients in
an aqueous environment tend to concentrate near a solid sur-
face (99). That many specialized structures and complex ligand
interactions have evolved in prokaryotes designed specifically
for surface recognition and biofilm formation is another clue
supporting the importance of microbial adhesion (2, 6). From
an evolutionary standpoint, the selective advantage of bacterial
adhesion has been postulated to favor the localization of sur-
face-bound bacterial populations in nutritionally favorable,
nonhostile environments and at the same time provide some
level of protection from external predation (18). When the
environment ceases to support the bacterial load, the equilib-
* Mailing address: Division of Laboratory Medicine, Department
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rium is shifted to favor dissociation of individual cells from the
biofilm to seek more favorable habitats (i.e., to go where no
bacterium has gone before).
The inclination for bacteria to colonize surfaces is a double-
edged sword, however, that can prove either beneficial or po-
tentially destructive. Whereas nitrogen fixation and bioreme-
diation of wastewater are beneficial functions of microbial
biofilms, biofouling, i.e., the obstruction of fluid flow through
conduits, over surfaces, through filters, or across heat exchang-
ers, and corrosion are major economic liabilities of the food,
maritime, petroleum, and manufacturing industries (8, 17). In
some instances, the corrosive damage caused by bacterial bio-
films provides a never-ending source of economic benefit, as
most of us have appreciated after a trip to the dentist.
Over the past century, the study of microbial adhesion has
generated a language all its own. Since many of these terms are
still in use, a brief discussion of their meaning with reference to
biofilm development would be apropos. The terms sessile and
planktonic have evolved to describe surface-bound and free-
floating microorganisms, respectively. The surface of interest
to which sessile organisms are attached can be either abiotic
(inert materials) or biotic (living tissue or cells). A glycocalyx is
the glue that holds the biofilm fast to the colonized surface and
is a complex of exopolysaccharides of bacterial origin and
trapped exogenous substances found in the local environment,
including nucleic acids, proteins, minerals, nutrients, cell wall
material, etc. (17). One of the more figurative descriptors to
appear in the bacterial adhesion literature is slime, a term used
by Heukelekian and Heller in 1940 (47) to describe a bacterial
biofilm layer and resurrected by Christensen et al. in 1982 (11)
to designate the glycocalyx produced by highly adherent strains
of Staphylococcus epidermidis recovered from infected biomed-
ical implants.
WHAT IS A BIOFILM?
Costerton et al. (20) define a biofilm as “a structured com-
munity of bacterial cells enclosed in a self-produced polymeric
matrix and adherent to an inert or living surface.” Elder and
colleagues (33) describe a biofilm in more cooperative terms as
“a functional consortium of microorganisms organised within
an extensive exopolymer matrix,” whereas Carpentier and Cerf
(8) simplify the concept as “a community of microbes embed-
ded in an organic polymer matrix, adhering to a surface.”
Underlying each of these definitions are the three basic ingre-
dients of a biofilm: microbes, glycocalyx, and surface. If one of
these components is removed from the mix, a biofilm does not
develop. Clearly, this is an oversimplification of a fairly com-
plex process that does not take into account the type of mi-
croorganism, the composition of the surface, or the influences
of environmental factors, but any of these definitions will serve
as a starting point for the balance of this review. Indeed, it will
be discussed later that a primitive yet functional degree of
organization and cooperativity exists with biofilms to allow
maximum interaction with the environment without compro-
mising cell survival or exhausting available resources. While a
diverse number of microorganisms are capable of generating
biofilms, only bacteria will be considered throughout this dis-
cussion.
BIOFILMS ARE UNIVERSAL
Virtually any surface—animal, mineral, or vegetable (i.e.,
biotic or abiotic)—is fair game for bacterial colonization and
biofilm formation, including contact lenses, ship hulls, dairy
and petroleum pipelines, rocks in streams, and all varieties of
biomedical implants and transcutaneous devices (for reviews,
see references 8, 17, 19, 20, and 33). In many circumstances,
the surface might also be a nutrient source, such as cellulose in
the paper industry (19). One has only to experience the process
of cleaning a J trap in a clogged sink drain to fully appreciate
the potential magnitude of bacterial biofilms and the process of
biofouling on a small scale. While surfaces or surface coatings
that retard bacterial adhesion have been described (86), none
have been developed that prevent it (18). Similarly, no bacte-
rial species has been observed to exist in a fully planktonic state
under all growth conditions (8, 12).
THE BIOFILM GLYCOCALYX: A BACTERIAL
FORCE FIELD
Bacterial exopolysaccharides are the main component of the
biofilm glycocalyx, which has also been coined the slime layer
(7, 16). When fully hydrated, the glycocalyx is predominantly
water (16). In most species, the glycocalyx is predominantly
anionic and creates an efficient scavenging system for trapping
and concentrating essential minerals and nutrients from the
surrounding environment (8, 17). We take advantage of the
scavenging ability of biofilms in the process of wastewater
treatment. As an added advantage, the glycocalyx provides a
certain degree of protection for its inhabitants against certain
environmental threats, including biocides, antibiotics, anti-
body, surfactants, bacteriophages, and foraging predators such
as free-living amoebae and white blood cells (reviewed in ref-
erences 8, 17, 19, and 33). In essence, the glycocalyx creates a
three-dimensional force field that surrounds, anchors, and pro-
tects surface-bound bacteria (Fig. 1).
BIOFILM DIVERSITY
When a biofilm is composed of heterogeneous species
(which is more likely in nature than single species), the meta-
bolic by-products of one organism might serve to support the
growth of another, while the adhesion of one species might
provide ligands allowing the attachment of others (17, 60, 66,
94). Conversely, the competition for nutrients and accumula-
tion of toxic by-products generated by primary colonizers can
limit the species diversity within a biofilm (66).
PROCESS OF BACTERIAL ADHESION
The process of bacterial attachment to an available surface
(living or abiotic) and the subsequent development of a biofilm
can be described in fairly simple or incredibly elaborate terms
depending on the level of detail required or sought. Obviously,
the process is dictated by a number of variables, including the
species of bacteria, surface composition, environmental fac-
tors, and essential gene products. As an oversimplified rule of
thumb, primary adhesion between bacteria and abiotic surfaces
is generally mediated by nonspecific (e.g., hydrophobic) inter-
actions, whereas adhesion to living or devitalized tissue is ac-
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complished through specific molecular (lectin, ligand, or adhe-
sin) docking mechanisms (8).
In its most basic form, bacterial adhesion (as a process
distinct from but integral in biofilm formation) can be divided
into two stages: the primary or docking stage and the second-
ary or locking phase (2, 76, 68). This process conjures up
images of the Russian Soyuz shuttle docking with the Mir
space station. Some authors will include an additional step in
this process called surface conditioning to describe the inter-
action of the substratum with its environment (6, 41). Condi-
tioning occurs, for example, when a foreign body is placed in
the bloodstream and the native surface is modified by the
adsorption of water, albumin, lipids, extracellular matrix mol-
ecules, complement, fibronectin, inorganic salts, etc. Once a
surface has been conditioned, its properties are permanently
altered, so that the affinity of an organism for a native or a
conditioned surface can be quite different.
Docking: Primary Bacterial Adhesion
Primary adhesion constitutes the serendipitous meeting be-
tween a conditioned surface and a planktonic microorganism.
This stage is reversible and is dictated by a number of physio-
chemical variables that define the interaction between the bac-
terial cell surface and the conditioned surface of interest (2,
67). First, the organism must be brought into close approxi-
mation of the surface, propelled either randomly (for example,
by a stream of fluid flowing over a surface) or in a directed
fashion via chemotaxis and motility. Once the organism
reaches critical proximity to a surface (usually 1 nm), the
final determination of adhesion depends on the net sum of
attractive or repulsive forces generated between the two sur-
faces. These forces include electrostatic and hydrophobic in-
teractions, steric hindrance, van der Waals forces, tempera-
ture, and hydrodynamic forces, to name a few (reviewed
eloquently in references 2 and 8). Electrostatic interactions
tend to favor repulsion, because most bacteria and inert sur-
faces are negatively charged (8, 54). Stenotrophomonas malto-
philia is one exception to this rule, and the overall positive
surface charge of this organism at physiological pH can pro-
mote primary adhesion to negatively charged materials such as
Teflon (54). Hydrophobic interactions probably have greater
influence on the outcome of primary adhesion (8).
Surface Conditioning
It is important to remember, however, that primary contact
generally occurs between an organism and a conditioned sur-
FIG. 1. Thin-section electron micrographs of exopolysaccharide obtained from a liquid culture of a mucoid strain of Pseudomonas aeruginosa.
The micrographs demonstrate individual cells (a and b) and microcolonies (c) entrapped in a matrix of alginic acid exopolysaccharide. Magnifi-
cation, 50,000 for panel a and 30,000 for panels b and c.
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face and the hydrophobicity of the latter can vary greatly de-
pending on the molecules in the conditioning film (2, 6). For
example, Wang et al. demonstrated that primary adhesion of
Staphylococcus epidermidis to polyethylene disks was enhanced
in the presence of surface-activated platelets and reduced by
adsorbed plasma proteins relative to uncoated polyethylene
(90). Using polymethylmethacrylate as a substratum, Herr-
mann et al. (46) showed that the adhesion of coagulase-nega-
tive staphylococci was enhanced when the surface had been
coated with various plasma proteins, including fibronectin.
Dunne and Burd (30), however, provided evidence that fi-
bronectin and proteolytic fragments of fibronectin produced a
dose-dependent reduction in the adhesion of S. epidermidis to
coated plastic surfaces, so there is plenty of room for further
elucidation.
A net repulsion between two surfaces can be overcome by
specific molecular interactions mediated by adhesins located
on structures extending from the cell surface, such as pili (2, 6).
The longevity of primary adhesion depends on the sum total of
all these variables, but surface chemistry pushes the equilib-
rium in favor of adhesion by predicting that organic substances
in solution will concentrate near a surface and that microor-
ganisms tend to congregate in nutrient-rich environs (8, 19,
99).
Locking: Secondary Bacterial Adhesion
The second stage of adhesion is the anchoring or locking
phase and employs molecularly mediated binding between spe-
cific adhesins and the surface (2). At this point, loosely bound
organisms consolidate the adhesion process by producing ex-
opolysaccharides that complex with surface materials and/or
receptor-specific ligands located on pili, fimbriae, and fibrillae,
or both. At the conclusion of the second stage, adhesion be-
comes irreversible in the absence of physical or chemical in-
tervention, and the organism is attached firmly to the surface
like a cocoon on a leaf. With certain organisms, several distinct
adhesins might be used for surface attachment depending on
the environment. In the case of Vibrio cholerae El Tor, a toxin-
coregulated pilus is used to attach to and colonize intestinal
epithelium during the process of human infection, whereas a
mannose-sensitive hemagglutinin is the primary adhesin used
to anchor to abiotic surfaces in an aquatic environment (91).
During this stage of adhesion, planktonic microorganisms
can also stick to each other or different species of surface-
bound organisms, forming aggregates on the substratum. In-
terestingly, the presence of one species of microorganism on a
surface can promote the adhesion of another (60, 70). All
bacteria produce multiple adhesins, and some are regulated at
the transcriptional level, permitting organisms to switch from
sessile to planktonic forms under different environmental in-
fluences (2, 96). Such is the case with S. epidermidis, which
produces a polysaccharide intercellular adhesin (PIA) that is
essential for cell-to-cell adhesion and subsequent biofilm for-
mation (42, 43, 64, 65).
BIOFILM MATURATION
Once bacteria have irreversibly attached to a surface, the
process of biofilm maturation begins. The overall density and
complexity of the biofilm increase as surface-bound organisms
begin to actively replicate (and die) and extracellular compo-
nents generated by attached bacteria interact with organic and
inorganic molecules in the immediate environment to create
the glycocalyx. In the case of infected biomedical implants, this
might include host-derived inflammatory response proteins or
matrix proteins such as complement, fibrinogen, fibronectin,
and glycosaminoglycans attached to the conditioned device.
The growth potential of any bacterial biofilm is limited by
the availability of nutrients in the immediate environment, the
perfusion of those nutrients to cells within the biofilm, and the
removal of waste. In addition, there exists an optimum hydro-
dynamic flow across the biofilm that favors growth and perfu-
sion rather than erosion of the outermost layers (8). Other
factors that control biofilm maturation include internal pH,
oxygen perfusion, carbon source, and osmolarity (8, 73). At
some point, the biofilm reaches a critical mass, and a dynamic
equilibrium is reached at which the outermost layer of growth
(farthest from the surface) begins to generate planktonic or-
ganisms. These organisms are now free to escape the biofilm
and colonize other surfaces. Cells nearest the surface become
quiescent or die secondary to a lack of nutrients or perfusion,
decreased pH, pO2, or an accumulation of toxic metabolic
by-products (57).
Recent evidence suggests that the primary development,
maturation, and breakdown of a biofilm might be regulated at
the level of population density-dependent gene expression
controlled by cell-to-cell signaling molecules such as acylated
homoserine lactones (1, 25, 69, 87). Once fully matured, a
biofilm generates altered patterns of bacterial growth, physio-
logical cooperation, and metabolic efficiency, all of which pro-
vide a form of functional communal coordination that mimics
primitive eukaryotic tissue (18, 19).
BIOFILM RESISTANCE TO ANTIMICROBIAL AGENTS
When dealing with infected biomedical implants, it is impor-
tant to recognize that bacteria present in a mature biofilm
behave quite differently from their planktonic counterparts. In
particular, biofilm organisms are far more resistant to antimi-
crobial agents than are organisms in suspension. In some ex-
treme cases, the concentrations of antibiotics required to
achieve bactericidal activity against adherent organisms can be
three to four orders of magnitude higher than for planktonic
bacteria, depending on the species-drug combination (9, 85).
At least three mechanisms have been proposed to account for
the increased resistance of biofilms to antimicrobial agents.
Biofilm as a Molecular Filter
The first of these mechanisms suggests that the biofilm gly-
cocalyx prevents the perfusion of biocides to cellular targets,
while the second recognizes the nearly dormant growth pattern
of bacterial populations within the biofilm that renders organ-
isms indifferent to antibiotic activity. The third proposes that
the microenvironment of the biofilm adversely affects the ac-
tivity of the antimicrobials (4, 9, 40, 85).
In support of the first of these proposals, Farber et al. (35)
found that cell extracts of the slime polysaccharide of S. epi-
dermidis interfered with the antimicrobial activity of glycopep-
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tide antibiotics. The addition of 0.5% slime extract to broth
microdilution susceptibility plates increased the MIC of both
vancomycin and teichoplanin approximately fivefold versus
both slime-positive and -negative strains. Slime also negated
the synergistic effects of both vancomycin and gentamicin while
having no effect on the activity of clindamycin, rifampin, and
cefazolin. The authors suggested that the slime either physi-
cally complexes with and inactivates glycopeptides or coats the
cell wall to create a permeability barrier. In an in vitro model,
however, Dunne et al. (31) showed that a slime-positive S.
epidermidis biofilm did not prevent the perfusion of vancomy-
cin or rifampin, nor could it be sterilized in the presence of
either or both antibiotics at concentrations exceeding bacteri-
cidal levels (Fig. 2). Nickel and colleagues (72) created an
artificial Pseudomonas aeruginosa biofilm on urinary catheter
material using a modified Robbins device and showed that
exposure to 1 g of tobramycin/ml for 12 h did not sterilize the
biofilm. Interestingly, the MIC of tobramycin for the surviving
organisms was not affected. In a related study, Nichols et al.
(71) investigated the binding of [3H]tobramycin to the alginic
acid exopolysaccharide produced by mucoid strains of Pseudo-
monas aeruginosa and to commercially prepared alginate. The
authors were able to show concentration-dependent binding of
tobramycin to both. As further evidence of this activity, the
addition of 1% alginate to tobramycin in a well diffusion assay
demonstrated reduced zones of inhibition versus Escherichia
coli and Staphylococcus aureus, indicating that this exopolysac-
charide interferes with either the antimicrobial action of the
drug or the perfusion of tobramycin through the medium.
These observations were supported by the report of Coquet
et al. (15), who exposed alginate-embedded biofilms of P.
aeruginosa to 15 times the MIC of tobramycin, 20 times the
MIC of imipenem, or both and compared the results to those
for planktonic cultures of the same organism. While the plank-
tonic cultures showed an approximately 100,000-fold reduction
in the viable cell count after 6 h of exposure to either tobra-
mycin or imipenem, neither drug produced more than a 1,000-
fold reduction in the viable cell count of embedded organisms
after 10 h of incubation. Furthermore, while the combination
of tobramycin and imipenem demonstrated a synergistic effect
against planktonic organisms, no such effect was observed with
alginate-embedded bacteria. Hoyle et al. (49) showed that bio-
films of P. aeruginosa established on dialysis membranes re-
tarded the diffusion of piperacillin. In the presence of Ca2,
the diffusion of piperacillin was completely prevented, presum-
ably by creating an alginic acid-Ca2 barrier matrix.
Increased Resistance Reflects Altered Growth Rates
Eng et al. (34) provided evidence in support of the second
theory of biofilm resistance, i.e., that altered rates of bacterial
growth dictate the response to antimicrobial agents. By con-
trolling the growth rate of bacteria through nutrient limitation,
the authors were able to demonstrate that only fluoroquino-
lone antibiotics produced bactericidal effects against station-
ary-phase gram-negative organisms. Furthermore, no class of
antimicrobial agent was bactericidal versus growth-limited S.
aureus. An increase in the nutrient concentration and subse-
quent growth rate was followed by an increase in the activity of
multiple classes of antimicrobial agents. Gander and Gilbert
FIG. 2. Scanning electron micrograph of an untreated biofilm of S. epidermidis (a) and an identical biofilm exposed to vancomycin and rifampin
for 72 h at concentrations exceeding the MIC and MBC for the organism (b). Despite obvious changes in the treated biofilm, viable organisms were
recovered for which the MIC and MBC of both agents were unaltered. Reprinted from reference 31 with permission of the American Society for
Microbiology.
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(37) used ciprofloxacin-treated E. coli biofilms to replicate
these findings. Anwar and others (3) were able to demonstrate
age-related differences in the response of S. aureus biofilms to
antimicrobial therapy. Exposure of 4-day-old biofilms to tobra-
mycin and/or cephalexin produced a rapid reduction in viable-
cell counts, whereas biofilms developed over a 13-day period
demonstrated marked resistance to either drug or a combina-
tion of both. The authors suggest that these findings are due, at
least in part, to the reduced metabolic activity of cells embed-
ded in the aged biofilm.
Does the Microenvironment Affect Antimicrobial Activity?
In terms of microenvironment, it is likely that the same
factors that adversely influence antimicrobial activity in vitro,
including pH, pCO2, pO2, divalent cation concentration, hy-
dration level, and pyrimidine concentration, will also produce
undesirable effects at the deepest layers of a bacterial biofilm
(53), where acidic and anaerobic conditions persist. While
detailed studies of these factors vis-à-vis antibiotic activity
in biofilm environs are lacking, one could predict, based on
disk diffusion and broth microdilution susceptibility testing,
that the activity of aminoglycosides, macrolides, and tetracy-
clines would likely be compromised in an acidic milieu with
increased pCO2. Also, the polyanionic nature of the alginic
acid exopolysaccharide of P. aeruginosa (28, 61) would cer-
tainly tend to concentrate divalent cations. This, in turn, would
also affect the activity of aminoglycosides and tetracyclines
(53).
All told, the intractability of biomedical implant infections to
successful antimicrobial therapy is likely a result of the com-
bination of the perfusion barrier, reduced growth rate, and
extreme microenvironmental conditions of the biofilm. The
use of antibiotics in the treatment of infected implants, how-
ever, likely pushes the equilibrium in favor of the sessile rather
than planktonic growth state.
BIOFILM ARCHITECTURE
Scanning the Surface
From a three-dimensional perspective, we tend to think of
bacterial biofilms as a mass of organisms uniformly distributed
throughout a polysaccharide matrix overlaying a surface. Noth-
ing could be further from the truth. Biofilms have been visu-
alized by a variety of means, including light microscopy with
computer enhancement, transmission electron microscopy,
and scanning electron microscopy (17, 55, 58, 81). Each of
these methods, however, has limitations, either due to issues of
resolution or by the creation of artifacts caused by dehydration
or processing techniques. Alternatively, scanning confocal la-
ser microscopy (SCLM) provides three-dimensional, noninva-
sive inspection and computer reconstruction of mature bio-
films without appreciable distortion of architecture in a
manner similar to computer-assisted tomography and mag-
netic resonance imaging methods.
Using SCLM and biofilms of P. aeruginosa, Pseudomonas
fluorescens, and Vibrio parahaemolyticus, Lawrence et al. (59)
were able to create an enhanced conceptual image of bacterial
biofilm architecture as it exists in nature. For these studies,
biofilms were generated with each of these organisms using
continuous-flow slide culture chambers and examined at vari-
ous time intervals. The results showed that V. parahaemolyticus
and P. aeruginosa produced biofilms that were approximately
two times the thickness of P. fluorescens biofilms. Each biofilm
demonstrated variation in depth and in the ratio of cellular to
noncellular material. All biofilms were highly hydrated, open
structures composed of 73 to 98% noncellular material, includ-
ing water channels and exopolysaccharide. The cells within
Pseudomonas biofilms were more tightly packed at the surface
and less dense near the periphery of the biofilm, i.e., pyramidal
in shape. Conversely, biofilms produced by V. parahaemolyticus
showed the opposite arrangement; cell density was greatest
near the periphery. In addition, V. parahaemolyticus biofilms
had extensive void spaces within the inner regions of the bio-
film. The authors proposed that the difference in architecture
demonstrated by V. parahaemolyticus biofilms might be due to
the expression of lateral flagella stimulated by surface contact,
as previously described (5).
The porosity and channels throughout Pseudomonas and
Vibrio biofilms allow the free diffusion of low-molecular-weight
compounds such as fluorescein, which indicates that the spatial
arrangement of cells, pores, and water channels within the
biofilm permits access to nutrients as well as antibiotics. This
presents somewhat of a paradox, in that biofilms appear to be
permeable to low-molecular-weight compounds and yet dem-
onstrate grossly elevated MBCs of antimicrobial agents that
show acceptable in vitro activity against planktonic cultures.
Three-Dimensional Perspective of Biofilms
Conceptually, if we were able to explore a bacterial biofilm
at a microscopic level (something like Isaac Asimov’s The Fan-
tastic Journey or the movie Honey, I Shrunk the Kids), it might
look like an underwater coral reef with pyramid or mushroom-
shaped projections extending away from the surface and chan-
nels and caverns running throughout. Instead of the calcified
exoskeleton, though, the viable organisms would be encased in
a gelatinous glycocalyx, giving the visual impression of a lava
lamp. As in a coral reef, the surface of a bacterial biofilm would
be fertile ground for secondary colonization by additional or-
ganisms. The hydrodynamic flow of liquid over and through
the biofilm would likely break fragments containing viable or-
ganisms away from the surface, which, in turn, would be car-
ried with the current and deposited elsewhere for further col-
onization.
The maximum growth potential of the coral reef or the
bacterial biofilm is ultimately limited by the availability of
nutrients and waste removal. In the case of bacterial biofilms,
growth is also limited by the expression of quorum-sensing
molecules released in response to nutrient limitation, accumu-
lation of toxic by-product, and possibly other factors (1, 25, 69,
73, 87).
PROTOTYPICAL BIOFILMS
Perhaps the two most intensely studied biofilm-producing
microorganisms of medical importance are P. aeruginosa and S.
epidermidis, the former because of its well-recognized ability to
achieve chronic pulmonary colonization in patients with cystic
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fibrosis and the latter for its propensity to infect biomedical
implants and transcutaneous devices. Rather than provide an
historical overview of the investigations which have contrib-
uted to current concepts regarding the role that biofilms play in
the diseases caused by each of these organisms, this section will
concentrate primarily on the molecular genetics that deter-
mine the course of biofilm formation. Because the story is
somewhat more complex and divergent, I will begin first with S.
epidermidis.
THE CONS BIOFILM FESTIVAL
In 1982, Christensen et al. (11) observed that strains of S.
epidermidis associated with an outbreak of catheter-related
sepsis were phenotypically distinguished from nonoutbreak
strains by their ability to form a dense, alcian blue-stained film
or slime layer on the inner aspect of glass culture tubes con-
taining Trypticase soy broth as a growth medium. Further-
more, scanning electron microscopic examination of slime-
positive strains grown on intravascular catheter sections
demonstrated dense growth of adherent organisms encased in
extracellular material. The authors presumed that this material
was polysaccharide in nature due to the staining properties of
alcian blue. Strains of S. epidermidis such as these have since
been shown to frequently produce biomedical implant infec-
tions of all kinds (82).
Since this report, several groups have attempted to chemi-
cally define the extracellular antigens of S. epidermidis associ-
ated with adhesion and/or slime production. For example, Pe-
ters et al. (77) characterized the extracellular slime substance
of S. epidermidis as a mannose-rich glycocalyx that is reactive
with concanavalin A. Tojo et al. (88) isolated a galactose-rich
capsular polysaccharide (CPA or PS/A) that might have a role
in the primary adhesion of S. epidermidis to smooth, abiotic
surfaces. In 1990, Christensen et al. (13) purified a protease-
and heat-stable, glucose-rich extracellular slime-associated an-
tigen (SAA) that was antigenically distinct from CPA. Based
on adhesion studies using CPA-positive, SAA-positive, and
SAA-negative strains, the authors concluded that CPA medi-
ated primary adhesion while SAA promoted surface accumu-
lation (i.e., biofilm maturation) of S. epidermidis. This helped
explain their observation that certain slime-negative strains
were still capable of producing a biofilm. To make matters
even more intriguing, Hussain et al. in 1993 (50) reported that
the bulk of the slime glycocalyx of S. epidermidis was composed
of teichoic acid fragments and protein.
Confused? Fortunately, the combined efforts of several in-
dependent laboratories began to put the pieces of the S. epi-
dermidis adhesion puzzle together during the latter half of the
90s into a unified and logical process that involves several
stages and functional gene products. A summary of these find-
ings is most easily explained if the entire process is broken
down into the components of primary adhesion, cellular accu-
mulation, and glycocalyx production.
What Makes S. epidermidis Stick?
Primary or nonspecific adhesion is likely the end result of
several variables, including cellular and surface hydrophobicity
(48, 75), expression of adhesion-specific antigens such as the
CPA-PS/A polysaccharide described by Tojo et al. (88), and
environmental factors discussed earlier in this review. In 1996,
however, Christine Heilmann and colleagues (42) found that a
Tn917 insertion mutant of S. epidermidis had lost the ability to
stick to a polystyrene surface. This mutant was significantly less
hydrophobic than the wild-type strain and had concomitantly
lost the expression of four cell surface proteins. Genetic re-
constitution of one of those proteins (60 kDa) completely
restored primary adhesion to plastic, giving rise to the theory
that specific adhesins are required for the first stage of biofilm
development. Further analysis showed that the 60-kDa adhesin
protein appeared to be a proteolytic fragment of a much larger
gene product that bears sequence homology to the major Alt
autolysin of S. aureus (44).
Secondary Adhesion of S. epidermidis and PIA
The second stage of biofilm development is characterized by
the surface accumulation of cellular aggregates (43). This stage
appears to be mediated by a polysaccharide antigen that pro-
motes intercellular adhesion (42, 63, 64). This polysaccharide
intercellular adhesin (PIA) is a product of the icaADBC gene
cluster (21, 43) and is a virulence factor in the pathogenesis of
foreign-body infections (83, 84, 95). Chemically, PIA is a sur-
face-associated, linear 1-6 N-acetyl-D-glucosaminylglycan
(65) that is similar if not identical to the hemagglutinin of S.
epidermidis (36).
The expression of icaA, icaD, and icaC is absolutely nec-
essary for the synthesis of PIA (38), but a number of biofilm-
negative, ica-positive phase variants of S. epidermidis have
been described in which the icaA and icaC genes are inac-
tivated by the insertion sequence IS 256 (95, 96). The pro-
cess, however, is reversible, and the excision of IS 256 from
these strains on subculture fully restores the ability to pro-
duce PIA and a biofilm (95, 96). In an icaprom::lacZ expres-
sion construct, Rachid et al. (80) found that subinhibitory
concentrations of tetracycline and quinupristin-dalfopristin
produced strong induction of the ica promoter, while peni-
cillin, oxacillin, chloramphenicol, clindamycin, gentamicin,
ofloxacin, and teichoplanin had no such effect. These find-
ings were confirmed using a quantitative in vitro biofilm
assay, indicating that certain treatment modalities could
theoretically produce undesirable effects leading to en-
hanced biofilm synthesis.
It is possible that other intrinsic factors are involved in
PIA-induced cellular aggregation. Dunne and Burd (29) dem-
onstrated that increasing concentrations of Mg2 enhanced
biofilm production by S. epidermidis, while EDTA caused a
dose-dependent decrease in the accumulation of cells on a
plastic surface. Interestingly, Hussain et al. (51) identified a
140-kDa extracellular protein in a strain of S. epidermidis that
appears to have the same function as PIA. The addition of
protease or antiserum directed against this protein prevents
the formation of cellular aggregates on surfaces. Given the
relative importance of biofilm formation to bacterial survival, it
is likely that a variety of secondary pathways have evolved in
bacteria in order to preserve this function.
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Biofilm Maturation of S. epidermidis and the Slime Layer
The final phase of biofilm maturation in S. epidermidis, gen-
eration of a slime glycocalyx, is not essential to the overall
process of surface colonization (13). Furthermore, it is possible
that the chemical composition of the slime material varies from
strain to strain (13, 50, 77, 88). Irrespective of the chemical
nature of the glycocalyx, it is likely that this material adds to
the stability of the biofilm, making biomedical implants colo-
nized with slime-positive strains even more difficult to sterilize.
Clearly, additional studies are required to achieve some con-
sensus as to the nature of the slime exopolysaccharide, but it is
certain that the process of biofilm formation by S. epidermidis
consists of multiple phases and might provide several attractive
targets to prevent foreign-body infections through the devel-
opment of vaccines. A schematic representation of this process
is depicted in Fig. 3.
THE PSEUDOMONAS AERUGINOSA MODEL
Pseudomonas Adhesion: Motility and the Twitch
The development of surface-associated biofilms by P. aerugi-
nosa is quite similar to that by S. epidermidis in that primary
adhesion, cellular aggregation, and glycocalyx production are ob-
served, but this organism adds an unusual twist to the process.
O’Toole and Kolter (74) generated 13 transposon insertion mu-
tants of wild-type P. aeruginosa strain PA14 that were surface
attachment deficient (sad). Unlike the wild-type parent strain, sad
mutants were unable to produce a substantial biofilm. Southern
blot analysis detected only a single transposon insertion for each
mutant. Three of the 13 mutants had become nonmotile, and the
insertion sequence of one was located in a DNA sequence having
40% identity to the flgK gene sequence of Salmonella enterica
serovar Typhimurium and Escherichia coli. The flgK gene of these
organisms codes for the flagellum-associated hook protein 1, and
its loss leads to the production of nonfunctional flagella and loss
of motility.
A second class of sad mutants was identified in which the
transposon insertion was located in genes (pilB and pilC and a
pilY1 homologue) coding for the synthesis of type IV pili.
These appendages are responsible for a peculiar surface-asso-
ciated motion known as twitching motility, not to be confused
with Elvis. Twitching motility is a creeping or walking-like
movement across a surface, thought to result from the exten-
sion and contraction of type IV pili (22, 92), almost like actin-
mediated pseudopod motility in eukaryotic cells. To place
these observations in perspective, the wild-type parent strain
first forms a surface monolayer of cells through primary adhe-
sion. Monolayer cells then “walk” via twitching motility to form
cellular aggregates on surfaces that eventually differentiate
into microcolonies. The sad mutants defective in flagellar mo-
tility are unable to form a monolayer of cells on a surface,
while the mutants deficient in type IV pili form monolayers but
not cellular aggregates. Taken together, these findings indicate
FIG. 3. Schematic representation of biofilm formation by S. epidermidis. Primary adhesion (step 1) of individual cells to a surface is influenced
by physical interactions (hydrophobic, electrostatic), which in turn might be influenced by cell surface adhesions. Cellular aggregation (step 2) is
mediated by polysaccharide intercellular adhesin (PIA), the gene product of the icaADBC gene cluster, and (speculatively) other factors, such as
divalent cations. The final phase (step 3) is characterized by the generation of a slime exopolysaccharide that encases surface-bound organisms in
a gelatinous matrix but is not essential to biofilm development.
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that flagellar motility is required for primary adhesion and type
IV pili are essential for cellular aggregation. It has been sug-
gested previously that flagellar motility might be necessary to
bring cells into close proximity with a surface (58). The asso-
ciation between motility and biofilm development has been
noted with other organisms, such as P. fluorescens and E. coli
(56, 78).
Pseudomonas Biofilm Maturation
In P. aeruginosa, the exopolysaccharide glycocalyx is alginic
acid, a linear polymer consisting of -1,4-linked D-mannuronic
acid and various amounts of its C-5 epimer L-guluronic acid
(28, 61). The synthesis of alginic acid is under the control of the
algACD gene cluster (23), similar to the ica gene locus of S.
epidermidis. The production of alginic acid by P. aeruginosa (as
determined by an increase in the activity of promoters that
regulate the genes responsible for the biosynthesis of alginate)
is upregulated in response to various environmental factors,
including high osmolarity, high oxygen tension, ethanol expo-
sure, and nitrogen limitation (26, 27, 97).
The algC gene codes for a phosphomannomutase that is
essential for the production of alginic acid at a key point of
regulation. Using a reporter gene construct (algCprom::lacZ),
Davies et al. (23, 24) were able to demonstrate that an in-
creased percentage of cells began to upregulate algC synthesis
following attachment to a glass surface. This activation was
initiated after 15 min of attachment, increased through 2 h of
incubation, and decreased thereafter. The expression of the
algC reporter gene by biofilm organisms was nearly 19 times
greater than that of planktonic cells. Furthermore, biofilm
organisms accumulated more than twice as much uronic acid
(as a marker of alginic acid synthesis) as surface-free organ-
isms. Cells that did not demonstrate increased expression of
algC had a greater likelihood of detaching from the biofilm.
These results strongly support the idea of surface activation
of glycocalyx production by P. aeruginosa, but since the algC
gene is also required for lipopolysaccharide synthesis, the re-
sults must be interpreted with some caution. The authors go on
to speculate that regulation of algC might also involve quorum-
sensing molecules such as the homoserine lactone family of
autoinducers. A schematic representation of the phases of
biofilm production by P. aeruginosa is depicted in Fig. 4.
PARTING OBSERVATIONS
Throughout the years, a multitude of methods have been
examined for the removal and/or prevention of bacterial bio-
films on surfaces, including the use of biocides and antibiotics,
ultrasound, chelation, scraping (called pigging in the oil indus-
try [17]), enzymatic digestion, and high-pressure spraying, to
name a few (8, 17, 39, 52). All have had variable and usually
temporary success. This is particularly true for infected bio-
medical devices, where the outcome of antimicrobial therapy is
dependent on overcoming the inherent resistance of surface-
bound organisms.
This finding highlights an interesting paradox that was dis-
cussed by Costerton et al. (17), i.e., susceptibility testing per-
formed in clinical microbiology laboratories necessitates the
use of pure cultures grown in nutritionally rich media and in a
FIG. 4. Schematic representation of biofilm formation by P. aeruginosa. Step 1 represents the primary adhesion of individual cells to a targeted
surface that is dependent on motility, i.e., the production of functional flagella. The aggregation phase (step 2) of biofilm development requires
the synthesis of type IV pili, which allow the cells to migrate across a surface and congregate in microcolonies. The final phase (step 3) of biofilm
development by P. aeruginosa calls for the elaboration of an alginic acid-like exopolysaccharide by the algACD gene cluster. Cells near the outer
surface can dislodge from the biofilm and escape to colonize new microenvironments.
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planktonic growth state. In reality, nothing could be further
from the conditions found in nature or in diseased individuals.
It is almost certain that the tendency for most, if not all,
bacteria to preferentially attach to surfaces is a fundamental
survival feature that evolved over millions of years to deal with
tremendous fluctuations in environmental conditions. In the
health care industry, we have rediscovered those tendencies
through the extensive use of transcutaneous catheters and bio-
medical implants. So why are we still testing the susceptibility
of microorganisms using planktonic growth conditions?
It might be time for clinical laboratories to explore new
means of testing organisms isolated from infected implants in
the growth mode that is most likely encountered in situ. Would
it not be better to report test results that hint at potential
treatment failures when dealing with bacteria in a biofilm than
to naively generate results that apply only to planktonic
growth? From studies of an animal model of S. epidermidis
foreign-body infection and an in vitro susceptibility assay using
biofilm organisms, Widmer et al. (93) astutely concluded
“Drug efficacy on stationary and adherent microorganisms, but
not minimum inhibiting concentrations [of planktonic organ-
isms], predicted the outcome of device-related infections.”
This conclusion was also reached by Anwar et al. (3), who
further lobbied for the development and use of a biofilm erad-
icating concentration (BEC) result as a means of predicting
therapeutic outcome for foreign-body infections.
A variety of in vitro models and devices have been specifi-
cally developed for research (3, 14, 32, 37, 57, 79, 93) and/or
commercial (9) applications but would require substantial eval-
uation, standardization, and education prior to routine use in
the clinical microbiology laboratory. Still, these efforts are cer-
tainly warranted if the ultimate goal is to better approximate
natural conditions and provide an accurate estimate of thera-
peutic outcome.
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